I G 225
Pill imprint I G 225 has been identified as Gemfibrozil 600 mg.
Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy.
Gemfibrozil 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Gemfibrozil Images
- Imprint:
-
I G
225 - Strength:
- 600 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium stearate
silicon dioxide colloidal
croscarmellose sodium
microcrystalline cellulose
methylcellulose (100 mPa.s)
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Major Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00904-5988
| NDC Code | Manufacturer / Repackager |
|---|---|
| 31722-0225 | Camber Pharmaceuticals Inc |
| 68084-0473 | Amerisource Health Services |
| 24658-0130 | Blu Pharmaceuticals LLC |
| 00143-9130 | West-Ward Pharmaceuticals |
| 67544-1111 | Prepak Systems Inc (repackager) |
| 53002-1068 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Gemfibrozil resources
- Gemfibrozil
- Gemfibrozil (Wolters Kluwer)
- gemfibrozil (Cerner Multum)
- gemfibrozil (Micromedex) - Includes Dosage Information
- Gemfibrozil (AHFS DI)
- Gemfibrozil (FDA)
- Gemfibrozil (Wolters Kluwer)
Search Again
